X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (990) 990
Book Review (83) 83
Publication (37) 37
Magazine Article (5) 5
Book Chapter (3) 3
Book / eBook (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (922) 922
index medicus (844) 844
female (569) 569
male (508) 508
adult (397) 397
papilledema - etiology (396) 396
ophthalmology (352) 352
papilledema - drug therapy (312) 312
papilledema - diagnosis (305) 305
middle aged (265) 265
papilledema (233) 233
adolescent (208) 208
child (169) 169
abridged index medicus (157) 157
clinical neurology (144) 144
visual acuity (136) 136
papilledema - chemically induced (131) 131
pseudotumor cerebri (130) 130
fluorescein angiography (128) 128
magnetic resonance imaging (121) 121
diagnosis, differential (109) 109
acetazolamide - therapeutic use (101) 101
intracranial hypertension (100) 100
treatment outcome (100) 100
aged (97) 97
pseudotumor cerebri - diagnosis (95) 95
idiopathic intracranial hypertension (94) 94
pediatrics (93) 93
pseudotumor cerebri - drug therapy (93) 93
fundus oculi (92) 92
glucocorticoids - therapeutic use (84) 84
papilledema - complications (82) 82
visual fields (80) 80
intracranial pressure (79) 79
pseudotumor cerebri - complications (79) 79
papilledema - pathology (77) 77
child, preschool (75) 75
drug therapy, combination (75) 75
headache - etiology (74) 74
diagnosis (70) 70
retrospective studies (69) 69
vision disorders - etiology (69) 69
tomography, optical coherence (67) 67
follow-up studies (66) 66
hypertension (64) 64
papilledema - physiopathology (62) 62
children (56) 56
young adult (55) 55
headache (51) 51
pseudotumor cerebri - etiology (51) 51
eye diseases (50) 50
prednisone - therapeutic use (49) 49
optic nerve (47) 47
pseudotumor cerebri - chemically induced (47) 47
pseudotumor cerebri - physiopathology (47) 47
animals (46) 46
pressure (46) 46
care and treatment (45) 45
neurosciences (45) 45
tomography, x-ray computed (45) 45
visual acuity - physiology (45) 45
adrenal cortex hormones - therapeutic use (44) 44
acetazolamide (43) 43
medicine & public health (43) 43
disease (42) 42
edema (41) 41
risk factors (41) 41
neurology (40) 40
prednisolone - therapeutic use (40) 40
anti-bacterial agents - therapeutic use (39) 39
prognosis (39) 39
infant (38) 38
vision disorders - diagnosis (37) 37
optic disk - pathology (36) 36
optic neuritis - drug therapy (36) 36
surgery (36) 36
health aspects (35) 35
intracranial hypertension - diagnosis (35) 35
carbonic anhydrase inhibitors - therapeutic use (34) 34
dexamethasone - therapeutic use (34) 34
optic neuritis - diagnosis (34) 34
time factors (34) 34
acute disease (33) 33
genetic structures (33) 33
medicine, general & internal (33) 33
recurrence (33) 33
drug therapy (32) 32
visual field tests (32) 32
blindness - etiology (31) 31
management (31) 31
obesity (31) 31
ophthalmoscopy (30) 30
optic neuropathy (30) 30
spinal puncture (30) 30
methylprednisolone - therapeutic use (29) 29
retinal hemorrhage - etiology (29) 29
intracranial hypertension - etiology (28) 28
pseudotumor cerebri - therapy (28) 28
anti-inflammatory agents - therapeutic use (27) 27
intracranial hypertension - drug therapy (27) 27
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (841) 841
German (51) 51
French (46) 46
Spanish (22) 22
Portuguese (8) 8
Italian (5) 5
Romanian (5) 5
Dutch (4) 4
Hebrew (4) 4
Danish (3) 3
Japanese (3) 3
Czech (2) 2
Polish (2) 2
Swedish (2) 2
Hungarian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2006, Volume 113, Issue 3, pp. 363 - 372.e5
To report the short-term safety, biologic effect, and a possible mechanism of action of intravitreal bevacizumab in patients with neovascular age-related... 
VERTEPORFIN | TISSUE-PLASMINOGEN ACTIVATOR | PHOTODYNAMIC THERAPY | PHARMACOKINETICS | FACTOR ANTIBODY FRAGMENT | INJECTION | COHERENCE TOMOGRAPHY FINDINGS | DISEASE | OPHTHALMOLOGY | ENDOTHELIAL GROWTH-FACTOR | SUBFOVEAL CHOROIDAL NEOVASCULARIZATION | Retina - drug effects | Choroidal Neovascularization - diagnosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Choroidal Neovascularization - etiology | Male | Retinal Detachment - drug therapy | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Bevacizumab | Antibodies, Monoclonal, Humanized | Choroidal Neovascularization - drug therapy | Retinal Detachment - diagnosis | Aged, 80 and over | Vitreous Body | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Fluorescein Angiography | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Fovea Centralis | Macular Degeneration - complications | Vascular Endothelial Growth Factor A - immunology | Visual Acuity | Choroidal Neovascularization - physiopathology | Pigment Epithelium of Eye | Injections | Antibodies, Monoclonal - administration & dosage | Papilledema - diagnosis | Aged | Retina - pathology | Papilledema - drug therapy | Macular degeneration | Physiological aspects | Eye diseases | Angiogenesis inhibitors | Index Medicus
Journal Article
Retina, ISSN 0275-004X, 04/2015, Volume 35, Issue 4, pp. 638 - 647
Journal Article
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 2008, Volume 17, Issue 2, pp. 49 - 54
Objective The data regarding diagnosis, prognosis, management, and outcome of patients with cerebral venous thrombosis are limited from the United States.... 
Neurology | Cardiovascular | venous | magnetic resonance imaging | Thrombosis | stroke | Intracranial Thrombosis - complications | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Thrombophilia - complications | Pregnancy Complications, Hematologic - drug therapy | Time Factors | Aged, 80 and over | Cerebral Hemorrhage - etiology | Intracranial Thrombosis - pathology | Bed Rest | Venous Thrombosis - drug therapy | Risk Factors | Anticoagulants - therapeutic use | Intracranial Thrombosis - etiology | Intracranial Thrombosis - mortality | Thrombolytic Therapy | Adolescent | Coma - drug therapy | Paresis - drug therapy | Pregnancy Complications, Hematologic - etiology | Cerebral Veins - pathology | Coma - etiology | Cohort Studies | United States | Venous Thrombosis - complications | Neoplasms - complications | Mobility Limitation | Adult | Female | Registries | Intracranial Thrombosis - drug therapy | Retrospective Studies | Paresis - etiology | Thrombophilia - drug therapy | Cerebral Hemorrhage - drug therapy | Venous Thrombosis - mortality | Magnetic Resonance Angiography | Treatment Outcome | Venous Thrombosis - etiology | Pregnancy | Cerebral Angiography | Aged | Venous Thrombosis - pathology | Papilledema - drug therapy | Papilledema - etiology | Analysis | Thrombophlebitis | Index Medicus
Journal Article
International Journal of Rheumatic Diseases, ISSN 1756-1841, 08/2010, Volume 13, Issue 3, pp. 246 - 252
Background: Ocular lesions, the main morbidity of Behcet's disease (BD), are the most difficult to treat. The aim of this study was to evaluate the efficacy of... 
Rituximab | Behcet's disease | Ocular lesions | EFFICACY | CYCLOPHOSPHAMIDE | B-CELL DEPLETION | INVOLVEMENT | AZATHIOPRINE | METHOTREXATE | RHEUMATOLOGY | TRIAL | IMMUNOSUPPRESSIVE THERAPY | ocular lesions | CHLORAMBUCIL | rituximab | MANIFESTATIONS | Single-Blind Method | Uveitis, Anterior - etiology | Azathioprine - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Methotrexate - therapeutic use | Retinal Vasculitis - physiopathology | Cyclophosphamide - therapeutic use | Uveitis, Anterior - physiopathology | Uveitis, Posterior - physiopathology | Young Adult | Papilledema - physiopathology | Visual Acuity - drug effects | Iran | Time Factors | Adult | Female | Prednisolone - therapeutic use | Drug Therapy, Combination | Uveitis, Posterior - etiology | Severity of Illness Index | Behcet Syndrome - complications | Treatment Outcome | Uveitis, Posterior - drug therapy | Pilot Projects | Adolescent | Immunosuppressive Agents - adverse effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Retinal Vasculitis - etiology | Uveitis, Anterior - drug therapy | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Papilledema - drug therapy | Papilledema - etiology | Retinal Vasculitis - drug therapy | Medicine, Experimental | Medical research | Corticosteroids | Methotrexate | Analysis | Immunosuppressive agents | Clinical trials | Cytotoxicity | Chemotherapy | Index Medicus
Journal Article
Journal of Infection, ISSN 0163-4453, 2012, Volume 66, Issue 4, pp. 330 - 337
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 2, pp. 789 - 798
Purpose To evaluate the intravitreal antivascular endothelial growth factor, bevacizumab, for treatment of radiation optic neuropathy (RON). Methods and... 
Radiology | Hematology, Oncology and Palliative Medicine | Optic neuropathy | Radiotherapy | Avastin | Bevacizumab | Plaque | TIME-DOSE FACTORS | SUBARACHNOID SPACE | CHOROIDAL MELANOMA | VISUAL RECOVERY | INTRAVITREAL INJECTION | HYPERBARIC-OXYGEN THERAPY | ONCOLOGY | MACULAR EDEMA | EXTERNAL-BEAM IRRADIATION | RETINOPATHY | VASCULAR-PERMEABILITY FACTOR | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiation Injuries - drug therapy | Prospective Studies | Intravitreal Injections | Humans | Middle Aged | Male | Angiogenesis Inhibitors - administration & dosage | Visual Acuity - drug effects | Antibodies, Monoclonal, Humanized - administration & dosage | Choroid Neoplasms - radiotherapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Eye Hemorrhage - drug therapy | Adult | Female | Antibodies, Monoclonal, Humanized - therapeutic use | Radioisotopes - adverse effects | Optic Nerve Diseases - drug therapy | Palladium - adverse effects | Neovascularization, Pathologic - drug therapy | Aged | Optic Nerve Diseases - etiology | Brachytherapy - adverse effects | Papilledema - drug therapy | Angiogenesis inhibitors | Ophthalmology | Nuclear radiation | Endothelial growth factors | Index Medicus | TOMOGRAPHY | PATIENTS | ATROPHY | BIOMEDICAL RADIOGRAPHY | HEMORRHAGE | SAFETY | MELANOMAS | GROWTH FACTORS | BLOOD VESSELS | EDEMA | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | SIDE EFFECTS | FLUORESCEIN
Journal Article
Klinische Monatsblatter fur Augenheilkunde, 09/2010, Volume 227, Issue 9, p. 681
The novel therapeutic principle of intravitreal drug therapy for retinal vein occlusion has become an integrated constituent of clinical practice over the last... 
Prognosis | Intravitreal Injections | Humans | Antibodies, Monoclonal - adverse effects | Dexamethasone - adverse effects | Endothelium, Vascular - drug effects | Laser Coagulation | Long-Term Care | Aptamers, Nucleotide - administration & dosage | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Papilledema - physiopathology | Ranibizumab | Hemodilution | Erythropoietin - metabolism | Retinal Artery - drug effects | Angiogenesis Inhibitors - adverse effects | Triamcinolone Acetonide - administration & dosage | Retinal Vein Occlusion - physiopathology | Dexamethasone - administration & dosage | Retinal Vein Occlusion - diagnosis | Retinal Vein - drug effects | Endothelium, Vascular - physiopathology | Combined Modality Therapy | Aptamers, Nucleotide - adverse effects | Retinal Vein - physiopathology | Triamcinolone Acetonide - adverse effects | Cell Division - drug effects | Randomized Controlled Trials as Topic | Cell Division - physiology | Adrenal Cortex Hormones - adverse effects | Retinal Artery - physiopathology | Retinal Vein Occlusion - drug therapy | Antibodies, Monoclonal - administration & dosage | Papilledema - complications | Blood Flow Velocity - physiology | Vascular Endothelial Growth Factor A - physiology | Adrenal Cortex Hormones - administration & dosage | Blood Flow Velocity - drug effects | Papilledema - drug therapy
Journal Article
Thyroid, ISSN 1050-7256, 05/2014, Volume 24, Issue 5, pp. 897 - 905
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2008, Volume 105, Issue 31, pp. 10925 - 10930
Journal Article